Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing

Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing

Item
http://www.wikidata.org/entity/Q37138015
New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutationsSTR DNA genotyping of hydatidiform moles in South China.EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: a meta-analysisKRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patientsComparison of uncommon EGFR exon 21 L858R compound mutations with single mutation.The mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order.EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations.Structural basis of mutant-selectivity and drug-resistance related to CO-1686.Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients[The research of clinical pathological features of ALK positive lung cancer in 525 patients and the discussion of detection methods].Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer
P2860

Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing

Item
http://www.wikidata.org/entity/Q37138015
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Screening for EGFR and KRAS mu ...... th PCR-based direct sequencing
@en
Screening for EGFR and KRAS mu ...... h PCR-based direct sequencing.
@nl
type
label
Screening for EGFR and KRAS mu ...... th PCR-based direct sequencing
@en
Screening for EGFR and KRAS mu ...... h PCR-based direct sequencing.
@nl
prefLabel
Screening for EGFR and KRAS mu ...... th PCR-based direct sequencing
@en
Screening for EGFR and KRAS mu ...... h PCR-based direct sequencing.
@nl
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P932
P1433
P1476
Screening for EGFR and KRAS mu ...... th PCR-based direct sequencing
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P932